Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals.
Clinical trial NCT07451561 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07451561
- Sponsor
- Sohag University
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-03-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.